Clindamycin Phosphate Injection, Solution
Product Images NDC 0338-9545

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Clindamycin Phosphate (NDC 0338-9545). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clindamycin Structural Formula (Image 01)

FDA Label Image

Clindamycin In Sodium Chloride Representative Container Label Ndc 0338-9545-50 (Image 02)

This is an intravenous injection medication containing Clindamycin Phosphate in 0.9% Sodium Chloride. The concentration is 300mg/50mL (6mg/mL). This medication is not to be used with supplementary medication and should only be used for intravenous infusion. Caution is recommended when inspecting for minute leaks or solution clarity. Each 50 mL contains 450mg of sodium chloride, 2mg of edetate, and water for infection. Dosage information should be obtained from the prescribing information. The medication should be stored between 20°C to 25°C. This medication is available by prescription only. Baxter is a registered trademark of Baxter International Inc. Baxter Healthcare Corporation is located in Deerfield, IL USA.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9545-24 1 Of 3 (Image 03)

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9545-24 2 Of 3 (Image 04)

The text contains information about a product named "GALAXY Container PL2501 Plastic" that seems to have been registered under the trademark "Baxter". The text also mentions "Baxter Healthcare Corporation" located in Desreld, IL 60015 USA, and the information that it was made in the USA. Additionally, the text includes information about a product named "Clindamycin Phosphate in 0.9% Sodium Chloride Injection" that comes in 12-50 mL Single Dose Containers and requires storage at controlled room temperature. Overall, the text provides limited information and no clear description.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9545-24 3 Of 3 (Image 05)

This is a description for a medication called Clindamycin phosphate that is administered intravenously. It comes in a 50 L container and each one contains 300 mg of clindamycin phosphate with sodium chloride and other substances. It is only for IV use and should not be used in any other way. It is important to check for leaks and solution clarity. Dosage information is available in the prescribing information.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Container Label Ndc 0338-9549-50 (Image 06)

This is a description of a pharmaceutical product labeled "Clindamycin Phosphate in 0.9% Sodium Chloride Injection". It contains 300mg of the active ingredient for every 50mL of the solution. The product code is 2G3455 and the NDC code is 0338-9545-24. The recommended storage temperature is between 20°C to 25°C and it is strictly for prescription use. The manufacturer/bottler's name is Baxter. It is advised to avoid storing the product above 30°C. The rest of the text seems to be a computer-generated code or serial number.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9549-24 1 Of 3 (Image 07)

This is a description of a medication called Clindamycin Phosphate, which is dissolved in 0.9% Sodium Chloride Injection. The medication is contained in a single-use container of 50 mL and is meant for intravenous infusion only. The cautionary information states not to add additional medications and to check for leaks and clarity of the solution. Each 50 mL dose contains 600 mg of Clindamycin Phosphate, 450 mg of Sodium Chloride, and other inactive ingredients. The medication should be stored at a temperature between 20°C to 25°C and discarded if not used. The manufacturer is Baxter Healthcare Corporation, and the medication is under the trade name of GALAXY.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9549-24 2 Of 3 (Image 08)

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9549-24 3 Of 3 (Image 09)

This is a description for a container labeled "GALAXY Container" with the registered trademarks of "Baxter" and "Galwy" of Baxter Healthcare Corporation in Desreld, Illinois. It is made of PL2501 Plastic and contains Clindamycin Phosphate in 0.9% Sodium Chloride Injection. The container holds 1250 ml as a single dose container that should be stored at a temperature between 20°C to 25°C (68°F or T7P) with controlled room temperature below 30°C.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Container Label Ndc 0338-9553-50 (Image 10)

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9553-24 1 Of 3 (Image 11)

Clindamycin Phosphate in 0.9% Sodium Chloride Injection is a medication with a strength of 600mg/50mL and the National Drug Code (NDC) is 0338-9549-24. It should be stored within the temperature range of 20°C to 25°C (68°F to 77°F), and temperatures above 30°C should be avoided. The medication is manufactured by Baxter. The rest of the text appears to be a code or batch number and manufacturing information.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9553-24 2 Of 3 (Image 12)

Clindamycin Phosphate in 0.9% Sodium Chloride Injection is a sterile and non-pyrogenic solution used for intravenous infusion only. Each 50 mL of the solution contains 900 mg of Clindamycin phosphate, which is equivalent to 300 mg of Clindamycin, 450 mg of sodium chloride, USP 2 mg edetate of sodium hydrate, USP, and water for injection, USP. The pH of the solution may have been adjusted with sodium hydroxide and/or hydrochloric acid. It comes with a Galaxy container that has a code of 2G3457. The unused portion of the solution should be discarded. It is cautioned not to add supplementary medication and not to use it in series connections. Dosage information should be obtained from the prescribing information. The storage temperature should be between 20°C to 25°C (66°F to 77°F) and should be not be exposed to temperatures above 30°C. Baxter Healthcare Corporation, located in Deerfield, IL, is the manufacturer of the product.*

FDA Label Image

Clindamycin In Sodium Chloride Representative Carton Label Ndc 0338-9553-24 3 Of 3 (Image 13)

FDA Label Image

Image 14

The text contains information about two products: GALAXY Container PL2501 Plastic, manufactured by Bader International Inc, and Clindamycin Phosphate in 0.9% Sodium Chloride Injection, containing 900mg per 50mL. The Clindamycin Phosphate Injection is stored at a temperature between 2°C to 25°C and comes in 12 to 50 mL single-dose containers. The GALAXY Container PL2501 Plastic has a registered trademark and is manufactured in the USA.*

FDA Label Image

Image 15

This appears to be a medication label containing information such as the drug name, dosage, and cautionary statements. The medication is intended for intravenous infusion only and is sterile and nonpyrogenic. The dosage information is included, but caution is advised not to add any supplementary medication. The label also includes the drug's NDC and code numbers.*

FDA Label Image

Image 16

Clindamycin Phosphate in 0.9% Sodium Chloride Injection is a prescribed medication available in a 50mL container with 900mg of clindamycin phosphate. The product code is 2G3457 and the NDC is 0338-9553-24. It should be stored at room temperature, between 20°C and 25°C (68°F to 77°F) and away from temperatures above 30°C. The medication is for medical use only and should be stored as per USP controlled room temperature guidelines. The excerpt also includes additional codes and references, but they don't provide further essential details about the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.